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Aims To identify key structural and electrophysiological features explaining distinct electrocardiogram (ECG) phenotypes




Human heart–torso anatomical models were constructed from cardiac magnetic resonance (CMR) images of HCM
patients, representative of ECG phenotypes identified previously. High performance computing simulations using bido-
main models were conducted to dissect key features explaining the ECG phenotypes with increased HCM Risk-SCD
scores, namely Group 1A, characterized by normal QRS but inverted T waves laterally and coexistence of apical and
septal hypertrophy; and Group 3 with marked QRS abnormalities (deep and wide S waves laterally) and septal hyper-
trophy. Hypertrophic cardiomyopathy abnormalities characterized from CMR, such as hypertrophy, tissue microstruc-
ture alterations, abnormal conduction system, and ionic remodelling, were selectively included to assess their influence
on ECG morphology. Electrocardiogram abnormalities could not be explained by increased wall thickness nor by local
conduction abnormalities associated with fibre disarray or fibrosis. Inverted T wave with normal QRS (Group 1A)
was obtained with increased apico-basal repolarization gradient caused by ionic remodelling in septum and apex.
Lateral QRS abnormalities (Group 3) were only recovered with abnormal Purkinje-myocardium coupling.
...................................................................................................................................................................................................
Conclusion Two ECG-based HCM phenotypes are explained by distinct mechanisms: ionic remodelling and action potential pro-
longation in hypertrophied apical and septal areas lead to T wave inversion with normal QRS complexes, whereas ab-
normal Purkinje-myocardial coupling causes abnormal QRS morphology in V4–V6. These findings have potential impli-
cations for patients’ management as they point towards different arrhythmia mechanisms in different phenotypes.
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Introduction
Hypertrophic cardiomyopathy (HCM) has remained a challenge due
to the extreme heterogeneity in its clinical course. Although most
patients are asymptomatic, HCM is a major cause of sudden cardiac
death (SCD) in young people due to ventricular arrhythmias. These
life-threatening arrhythmias are effectively aborted by implantable
cardioverter-defibrillators (ICDs) and the focus of risk stratification is
to target high-risk patients with an ICD. The electrocardiogram
(ECG) is abnormal in the majority of patients from abnormal Q
waves, ST segments, T-waves to wide QRS.1,2 However, the electro-
cardiographic signature of HCM has been inconclusive for reliable
risk stratification.3
Progress towards risk stratification was achieved in recent work,4
where four HCM phenotypes were identified using computational
analysis of the ECG. The greatest deviation from a normal ECG oc-
curred in two of the four ECG phenotypes: Group 1A and Group 3.5
Patients in Group 1A had normal QRS morphology, inverted T waves
laterally, increased HCM Risk-SCD scores, and coexisting septal and
apical hypertrophy. Patients in Group 3 had QRS abnormalities with
deep wide S waves laterally and septal hypertrophy. The structural
and electrophysiological sources of these different ECG phenotypes
in HCM remain unclear and complex, as they may include hypertro-
phy, fibre disarray, fibrosis, ionic remodelling, as well as Purkinje ab-
normalities.6–8 A better understanding of the electrophysiological
and structural basis of the HCM phenotypes may help to improve
personalized patient management, as the mechanisms underlying ar-
rhythmic risk may differ.
The goal of this study is to identify the key HCM structural and
electrophysiological features underlying the patients’ phenotypes
with more abnormal ECGs. We hypothesise that abnormalities in the
microstructure such as fibre disarray may explain abnormal electrical
activation and marked QRS abnormalities in Group 3, and that apical
HCM ionic remodelling may lead to primary repolarization prolonga-
tion and inverted T waves in Group 1A. To achieve these aims, we
exploit the power of high performance computing simulations of the
ECG using human biophysically-detailed torso-ventricular models





This study focused on the interpretation of the ECG morphologies of
patients from Group 1A and 3 identified in Ref.,4 which exhibited the
greatest deviation from a normal ECG. As a reference, simulations were
also conducted for Group 1B, which had normal QRS and T wave mor-
phologies. One representative patient was chosen from each of the HCM
phenotypic groups based on the presence of the characteristic ECG fea-
tures (Group 1B: normal QRS, upright T waves in V4–V6, Group 1A: nor-
mal QRS, inverted T waves in V4–V6, Group 3: short R duration and
amplitude, long S duration and amplitude in V4–V6) (Figure 1A), and the
presence of the characteristic hypertrophic areas on the CMR images
(Group 1A: mixed pattern of septal and apical hypertrophy, Groups 1B
and 3: septal hypertrophy) (Figure 1B).
Cardiac magnetic resonance-based
heart–torso models
Biventricular heart, torso, lungs, and ribs meshes were derived from
CMR scans of each patient by image processing, and virtual ECG electro-
des were positioned on the torso surface in standard placement to simu-
late the 12-lead ECG (see Supplementary material online, 1.1).
Human ventricular membrane kinetics were represented by modified
versions of the human ventricular electrophysiological O’Hara–Rudy
model for healthy10 and HCM cardiomyocytes.7 The models are
biophysically-detailed and include representation of sodium, calcium, and
potassium ionic currents as well as calcium dynamics. Hypertrophic cardi-
omyopathy-related ionic remodelling was represented by altering so-
dium, calcium, and potassium currents as described in Ref.7 Myocardial
and torso conductivities and ventricular fibre architecture were set as de-
scribed in Supplementary material online, 1.2. Electrophysiological heter-
ogeneities were introduced to represent the dispersion of action
potential duration (APD) in ventricular repolarization (see
Supplementary material online, 1.3). To simulate sinus rhythm, endocar-
dial activation was initiated in root nodes (or sites of earliest activation)
connected with a fast activating endocardial layer as in Ref.,9 representing
a phenomenological model of Purkinje-ventricular coupling connected to
the rest of the working myocardium (see Supplementary material online,
1.2). The location of early activation nodes in all our heart geometries
were selected to follow correspondent anatomical locations by mapping
homologous anatomical regions, such as insertion points, apex, and lateral
walls, among all geometries. The electrophysiological model was there-
fore kept the same in all cases in order to isolate the effect of each HCM-
related feature on the ECG, rather than aiming at matching the clinical
ECG in a patient-specific approach. Variability in body conductivities,
which has been shown to strongly affect QRS amplitude9 may be respon-
sible for differences in wave amplitude between simulated and clinical
ECGs. Analysis and comparisons of the ECG signals were therefore
made in terms of overall morphology and polarity.
Hypertrophic cardiomyopathy
abnormalities
Several hypotheses were tested to explain the ECG phenotypes in HCM,
based on CMR-based features and HCM electrophysiological and
What’s new?
• Simulations using multiscale whole-organ computer models
based on cardiac magnetic resonance images dissect the influ-
ence of structural and electrophysiological abnormalities on
the electrocardiogram (ECG) in hypertrophic cardiomyopathy
(HCM).
• Increased wall thickness, fibre disarray, bundle block, or myo-
cardial abnormalities do not account for the different ECG
phenotypes identified in HCM.
• An abnormal Purkinje-myocardium coupling is the only mecha-
nism we found that could explain the QRS abnormalities with
deep and wide S waves in lateral leads observed in one patient
group.
• Apico-basal repolarization heterogeneities due to ionic remod-
elling in coexisting regions of septal and apical hypertrophy ex-
plain the normal QRS and inverted T waves observed in the
phenotype associated with increased sudden cardiac death risk
score.
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structural understanding (Figure 1C). The anatomy (increased wall thick-
ness) was intrinsically included in the heart–torso models as they were
personalized from CMR images. Abnormalities in tissue microstructure
were also investigated. Fibre disarray was modelled as an isotropic con-
duction in the regions of low fractional anisotropy obtained from diffu-
sion tensor imaging (DTI) data. Decreased conduction velocity (such as
due to fibrosis, known to affect HCM hearts6) was modelled in those
areas as a four-time reduction in tissue conductivities, resulting in reduced
conduction velocity of 20 cm/s. Conversely, hypertrophied cells have
been shown to lead to increased conduction velocity in earlier stages of
left ventricular hypertrophy.11 Such an effect was therefore additionally
investigated by a four-time increase in conductivities, leading to an in-
creased conduction velocity in the regions of hypertrophy.
Bundle branch blocks have also been reported in HCM,12,13 and the ef-
fect of various blocks in the conduction system on the ECG were there-
fore tested (left bundle branch block, LBBB; left ventricular posterior and
anterior hemiblocks; right bundle branch block, RBBB) by deleting associ-
ated root nodes in the model.9 In addition, slurred S wave morphologies
Figure 1 Investigation of the effect of HCM abnormalities on the ECG. (A) ECG morphologies of the HCM phenotypes studied: Group 1B with
normal ECG morphology in V4–V6, Group 3 with QRS abnormalities with deep and wide S waves in V4–V6, and Group 1A with normal QRS mor-
phology but inverted T waves in V4–V6. (B) Personalized 3D volumetric meshes of the heart and torso are computed for each representative patient.
(C) The effect of HCM abnormalities (anatomy, tissue microstructure, conduction system, and ionic remodelling) on the ECG are investigated using
computer simulations. CMR, cardiac magnetic resonance; ECG, electrocardiogram; HCM, hypertrophic cardiomyopathy.
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in V5–V6 may be typical of RBBB, suggesting its potential implication in
the QRS abnormalities of Group 3 patients. Abnormal Purkinje-
myocardium coupling, as reported in HCM patients,8 was induced by a
mismatch between the fast endocardial layer and the myocardium intro-
duced by doubling conductivities. Fast propagation regions have been
shown capable of creating unidirectional propagation block because of
source-sink mismatch.14 Finally, HCM ionic remodelling was introduced
in the regions of hypertrophy, as described in Ref.7 This consisted in an al-
teration of the cellular ionic properties, mainly including an increase of
the late sodium and the L-type calcium current, reduction of the potas-
sium currents, and remodelling of the calcium handling subsystem.
Results
Effect of cardiac anatomy on the
electrocardiogram phenotypes in
hypertrophic cardiomyopathy
The anatomical effects of cardiac shape, hypertrophy distribution,
and extent on the ECG were investigated by patient-specific geome-
tries derived from CMR images (Figure 2). Despite characteristic dis-
tributions of hypertrophy in each group, the simulations yielded
similar QRS morphology and upright T waves in all groups, which
were consistent with the clinical ECG from Group 1B. As a sensitivity
analysis, we also analysed the influence of varying both the
intracellular and extracellular conductivities on the shape of the QRS.
Conductivity changes did not lead to morphological abnormalities
such as narrow tall R waves and deep wide S waves as seen in Group
3 (see Supplementary materials online, 2.1). Therefore, increased
wall thickness alone did not explain abnormalities in QRS morphol-
ogy in Group 3, or the T wave inversion in Group 1A.
Effect of abnormalities in tissue
microstructure on the QRS complex
Effect of local isotropic electrical propagation due to fibre
disarray
Hypertrophic cardiomyopathy hearts exhibit structural abnormalities
such as fibre disarray, which corresponds to a disarrangement of the
cardiac fibres and a loss of the normal electrical anisotropy property
of the cardiomyocytes. This may affect ventricular activation, and in
turn the QRS complex, as observed in Group 3 patients. However,
the introduction of isotropic electrical conduction in areas with low
fractional anisotropy from DTI made little change to the simulated
ECG in Group 3 (see Supplementary material online, 2.2).
Effect of altered conduction velocity by fibrosis and
hypertrophy
We then evaluated the potential impact of slowed electrical conduc-
tion in four different regions of the myocardium on the ECG
Figure 2 Effect of the anatomy on the ECG phenotypes observed in HCM. Simulated ECG of representative patients in Group 1B (A), Group 3
(B), and Group 1A (C) for leads V1–V6 along with their personalized heart anatomy. Arrows indicate areas of hypertrophy. ECG, electrocardiogram;
HCM, hypertrophic cardiomyopathy.
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Figure 3 Effect of changes in conduction speed (due to fibrosis, hypertrophy) on the QRS. (Top) Clinical ECG of Group 3 patient (black). (A)
Simulated QRS with slow conduction in various locations of the myocardium (mid-septum, left ventricular basal free wall, apex and septum from
base to apex), highlighted in red. (B) Simulated QRS with fast conduction in various locations of the myocardium (mid-septum, left ventricular basal
free wall, apex and septum from base to apex), highlighted in red. Simulated QRS in control conditions is represented in blue. Black arrows represent
lead of interest discussed in the text. ECG, electrocardiogram; LV, left ventricular.
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(Figure 3A). Slowing conduction in a mid-septal region yielded abnor-
mal QRS morphologies in septal and anterior leads V1–V4. Slowing
conduction in the left ventricular basal free wall did not affect the
QRS in the septal leads V1–V3, despite a smoother upright S slope to
the baseline. QRS in leads V4–V6 showed a similar morphology but
increased width. Slowing conduction in the apex affected mostly
leads V4–V6 with severely abnormal patterns of wide QRS. Finally,
slowing down conduction in a region covering the entire septum
from base to apex led to severe QRS abnormalities in septal leads
V2–V4, with reduced QRS amplitude and increased width, but similar
morphologies in leads V5–V6. The abnormalities in leads V1–V4 with
the entire septum affected were milder than in the case of the mid
septal region being affected. This was explained by the large activa-
tion delays in the anterior of the ventricles caused by the region of
slow conduction in the mid septum, which extended to the anterior.
These were not present in the entire septum case (see activation
maps in Supplementary material online, 2.3, Figure S4). Importantly
none of the changes introduced resulted in the deep S waves in leads
V4–V6 observed in Group 3.
We then considered that the increased surface-to-volume ratio of
hypertrophic myocytes could also lead to an increase in electrical
propagation speed.11 Faster conduction in both apical and septal
regions increased the QRS amplitude and reduced the QRS width in
leads V3–V4, but did not lead to a deep S wave in leads V5 and V6
(Figure 3B). Altogether, these results showed that positive or negative
changes in the conduction speed in local regions of the myocardium
did not produce a deep S wave in leads V4–V6, and therefore could
not explain the abnormalities observed in Group 3 patients.
Effect of abnormalities in the conduction
system on the QRS complex
Effect of altered early activation sites
Presence of branch blocks, such as LBBB or RBBB, has been
reported in HCM.12,13 We, therefore, investigated the effect on
the ECG of hypertrophic ventricles of various combinations of ac-
tivation blocks (Figure 4). Simulation results showed that various
combinations of activation blocks in the left ventricle affected the
duration of the activation, and therefore, the width of QRS com-
plexes, but did not change the overall morphology of the QRS in
lateral leads. Blocking the activation in the left ventricle free wall
(LBBB) led to wider QRS complexes in V1–V6 due to slow activa-
tion of the left ventricle. Knocking out the posterior branch of the
left ventricle did not affect the morphology of the QRS in any leads,
slightly increasing the amplitude of the QRS in V2–V4. Knocking
out the anterior branch of the left ventricle had very little effect on
the QRS, slightly increasing the QRS width, and did not affect wave
polarities. Finally, we investigated the effect of blocking the early
activation in the right ventricle (RBBB). This led to a slight increase
in amplitude and width of the S waves in lateral leads, but main-
tained the prominence of the R wave in V4–V6. The precordial
leads V1–V3 were strongly affected and showed abnormalities not
observed on the ECG of Group 3 patients.
We concluded that altering the activation sequence of the left and
right ventricles did not lead to the morphological abnormalities ob-
served in the lateral leads V4–V6 combined with normal QRS mor-
phology in leads V1–V3.
Effect of abnormal Purkinje-myocardium coupling
The abnormal Purkinje-myocardium coupling, modelled as described
in Methods section, led to a patchy activation and a diffuse activation
sequence compared with the control simulation (Figure 5A and B).
This led to the presence of late-activated areas in the myocardium
compared with the control simulation, especially in the right ventricle
base and endocardium, and the apex (Figure 5C). This translated into
deep and wide S waves in lateral leads V4–V6 of the ECG, without af-
fecting the morphology of the septal leads (Figure 5D). Therefore, an
abnormal coupling between branches of the Purkinje system and the
ventricular endocardium was the only way to reproduce the QRS
polarity abnormalities in Group 3, with abnormal deep and wide S
wave in the lateral leads. Affecting the myocardial propagation or the
early activation sequence did not explain them.
Effect of hypertrophic cardiomyopathy
ionic remodelling on Twave polarities
In order to investigate the phenotype of Group 1A patients, we hy-
pothesized that HCM ionic remodelling, resulting in longer APD in
the region of hypertrophy (combined septum and apex) may trans-
late in an inversion of the T wave in leads V4–V6. The HCM ionic
remodelling described in Ref.7 was modelled in the septum and apex,
in agreement with the mixed pattern of hypertrophy of these
patients. This led to an increased APD in the region of hypertrophy
(455 ms with HCM ionic remodelling vs. 324 ms without). The simu-
lated T waves showed inversions in the lateral leads V4–V6, while the
T waves in other leads remained unaffected (Figure 6A). This repli-
cated the morphology of the clinical ECG of Group 1A patients in all
leads. The QRS complex, representing the activation phase of the
cardiac cycle, was not affected by HCM ionic remodelling. The ionic
remodelling modelled in the apex only also led to inverted T waves
in the lateral leads (Figure 6B). Interestingly, ionic remodelling mod-
elled only in the septum (Figure 6C) did not yield inverted T waves in
leads V4–V6, confirming the crucial role of the apical hypertrophy in
Group 1A phenotype. Indeed, Group 1A was the only one exhibiting
mixed apico-basal hypertrophy and inverted T waves, while the other
groups only exhibited septal hypertrophy. This confirmed that apico-
basal heterogeneities due to ionic remodelling in the septal and apical
hypertrophied region may be responsible for the primary repolariza-
tion abnormalities observed in Group 1A, expressed as inverted T
waves and normal QRS morphology.
Discussion
High performance computing simulations using CMR-informed hu-
man torso-ventricular models have provided strong evidence that
the two phenotypes displaying more abnormal ECGs in HCM may
be explained by two distinct mechanisms, with potential relevance to
patients’ management. Hypertrophic cardiomyopathy patients with
inverted T wave and normal QRS (Group 1A) were affected by
apico-basal repolarization gradients caused by ionic remodelling in
septal and apical hypertrophy regions. Hypertrophic cardiomyopathy
patients with QRS abnormalities in the lateral leads (Group 3) were
affected by abnormal coupling between Purkinje branches and myo-
cardium. These simulations have also shown that anatomical and
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Figure 4 Effect of early activation sites knock-outs on the QRS. (Top) Clinical ECG of Group 3 patient (black). Changes in the activation sequence
with different blocking combinations (left bundle branch block, posterior block, anterior block, and right bundle branch block). Activation maps in
both ventricles are shown along with the specific simulated ECG (red), normal simulation (blue) in leads V1–V6. Black arrows represent lead of inter-
est discussed in the text. ECG, electrocardiogram.
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microstructural abnormalities alone could not explain the distinct
ECG abnormalities identified in each HCM phenotypes.
Hypertrophic cardiomyopathy structural
abnormalities: hypertrophy, disarray and
fibrosis
Ventricular anatomical abnormalities alone did not yield any of the
ECG abnormalities identified in the HCM phenotypes, either QRS
abnormalities or T wave inversions. Therefore, this suggests that left
ventricular hypertrophy may not be a major driver in the identifica-
tion of the distinct ECG phenotypes in HCM and may not, on its
own, strongly contribute towards higher arrhythmic risk in HCM
patients, as highlighted in previous studies.15 The effects of other
HCM abnormalities, such as fibre disarray (modelled as isotropic
electrical propagation) or changes in conduction speed due to fibro-
sis or hypertrophy, were simulated. However, none of these changes
in myocardial conduction reproduced the QRS abnormalities ob-
served in Group 3. This agrees with studies of HCM families exhibit-
ing myofibre disarray in the absence of ventricular hypertrophy,
where no QRS abnormalities were reported.16 Altering the activa-
tion sequence by modelling various activation knock-outs did not
yield these abnormal morphologies either.
Abnormal Purkinje-myocardium
coupling
Affecting the Purkinje-myocardium coupling was the only way to re-
produce the abnormalities in QRS complex characteristic of Group
3. We modelled a reduced coupling in the Purkinje branches coupled
to the endocardium, which led to a patchy activation with areas of
late activation, and translated to deep and wide S waves in lateral
leads V4–V6 on the ECG. This is in agreement with a study reporting
large Purkinje-muscle junction delays in HCM patients.8 These find-
ings may illustrate an abnormal Purkinje conduction in these patients,
also in agreement with studies reporting 23% of HCM patients with
abnormal His-Purkinje conduction system.17 Cases of HCM patients
with abnormal His-Purkinje system were also reported in Ref.,18
with the mention of a patient exhibiting a deep S wave morphology in
V6. Invasive studies such as endocardial mapping may help investigate
Figure 5 Effect of an abnormal Purkinje-myocardium coupling on the QRS. (A) Patchy activation in the simulation with abnormal Purkinje-myocar-
dium coupling compared with the normal conduction. (B) Activation maps for the simulation with abnormal Purkinje-myocardium coupling show dif-
fuse activation. (C) The simulation with abnormal Purkinje-myocardium coupling shows regions of late activation (blue) compared with the normal
simulation. (D) Modelling of altered fast propagation system (red) with normal simulation (blue) in leads V1–V6. Clinical ECG is shown in black. ECG,
electrocardiogram.
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Figure 6 Effect of ionic remodelling in the region of hypertrophy on the T wave. (Top) Clinical ECG of Group 1A patient (black). (A) Simulated
ECG with ionic remodelling in the septum and apex (red area) for leads V1–V6. (B) Simulated ECG with ionic remodelling in the apex (red area) for
leads V1–V6. (C) Simulated ECG with ionic remodelling in the septum (red area) for leads V1–V6. ECG, electrocardiogram; HCM, hypertrophic
cardiomyopathy.
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the extent of this possible mechanism. Future studies based on late
gadolinium enhancement data, exploring the presence of myocardial
fibrosis or scaring affecting the coupling of Purkinje fibres with the en-
docardium,19 may also provide insight.
Apex-base repolarization
heterogeneities
Longer APD in the hypertrophic area (combined septum and apex)
due to HCM ionic remodelling led to T wave inversions in leads V4–
V6 in Group 1A, without affecting the normal morphology of the
QRS complex. The location of these ionic abnormalities was in agree-
ment with the unique hypertrophy distribution in these patients.
Group 1A was indeed the only HCM phenotype exhibiting coexis-
tence of apical and septal hypertrophy, suggesting that ionic remodel-
ling abnormalities may occur in the hypertrophied region of these
patients.
Clinical implications
These results highlighted two different potential mechanisms for
ECG abnormalities associated with increased risk of SCD in HCM.
Abnormal Purkinje conduction may explain the QRS abnormalities in
the lateral leads in Group 3 patients with deep and wide S waves,
while ionic remodelling in the region of hypertrophy may be the
mechanism responsible for inverted T waves in Group 1A patients.
Group 1A patients presented a higher HCM risk score of SCD com-
pared to other groups, especially Group 3.4 This suggests that repo-
larization gradients due to ionic remodelling may play a key role in
arrhythmogenesis, as suggested in Ref.20 Conduction abnormalities
in the Purkinje system may be less pro-arrhythmic as they may not
perturb the overall synchronicity of the cardiac cycle. The very differ-
ent nature of these two mechanisms shows potential implications in
personalised treatment of HCM patients. For example, patients with
Group 1A phenotype may benefit from pharmacological block of late
sodium current as suggested in Ref.,7 whereas this may be ineffective
in Group 3 patients. Our study reinforces the importance of compu-
tational ECG phenotyping and modelling in risk assessment and pa-
tient management. Future work using techniques, such as endocardial
or epicardial mapping, will be needed to verify the hypotheses gener-
ated and improve the understanding of the connection between
structure and function in HCM patients.
Conclusions
High performance computing simulations using CMR-informed
torso-ventricular models were conducted to unravel key structural
and electrophysiological features explaining abnormalities in specific
ECG-based phenotypes of HCM patients.4 A personalized whole-
body simulation framework allowed the impact of hypertrophy, fibre
disarray, conduction speed and ionic remodelling on the ECG to be
quantified. Simulations highlight the existence of distinct mechanisms
for the phenotypes at higher risk. An abnormal Purkinje-myocardium
coupling may explain the QRS abnormalities in one of the HCM phe-
notypes at higher risk, whereas apico-basal repolarization gradients in
the regions of hypertrophy may explain the primary repolarization
abnormalities observed in another phenotype with increased HCM
Risk-SCD scores, exhibiting inverted T wave and normal QRS with
coexistence of septal and apical hypertrophy. Overall, this study pro-
vided novel hypotheses for structure-function relationships in HCM
that may be tested by further studies. We confirm the importance of
HCM phenotyping for patient management, and the potential of
computer modelling and simulation in describing and understanding
cardiac heterogeneity and disease.
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